Skip to main content

SPIDIA for Personalized Medicine - Standardisation of generic Pre-analytical procedures for In-vitro DIAgnostics for Personalized Medicine

Objective

Molecular in vitro diagnostics and biomedical research have allowed great progress in personalised medicine but further progress is limited by insufficient guidelines for pre-analytical workflow steps (sample collection, preservation, storage, transport, processing etc.) as well as by insufficient quality assurance of diagnostic practice. This allows using compromised patients’ samples with post collection changes in cellular and extra-cellular biomolecules’ profiles thus often making diagnostic test results unreliable or even impossible. To tackle this, SPIDA4P aims to generate and implement a comprehensive portfolio of 22 pan-European pre-analytical CEN/Technical Specifications and ISO/International Standards, addressing the important pre-analytical workflows applied to personalized medicine. These will also applicable to biomarker discovery, development and validation as well as to biobanks. Corresponding External Quality Assurance (EQA) Schemes will be developed and implemented as well, aiming to survey the resulting quality of samples and diagnostic practice. SPIDIA4P will ensure stakeholder organisations involvements as well as training, education, and counselling as additional major foci of the project. The consortium will closely coordinate with large European public research consortia to obtain access to research and validation studies data serving as evidence for the new standards developments and achieved improvements of diagnosis, patient stratification and prognosis of disease outcome.
At this crucial moment in the development of personalised medicine, SPIDIA4P proposes a coordination and support action that reunites 19 highly experienced partners in international standardisation for in vitro diagnostics, coming from private industry including SMEs, public institutions and from one official European Standards Organisation. This strong consortium is balanced and empowered to maximise the impacts of in vitro diagnostics on personalised medicine.

Field of science

  • /natural sciences/biological sciences/biochemistry/biomolecules
  • /social sciences/social and economic geography/transport

Call for proposal

H2020-SC1-2016-RTD
See other projects for this call

Funding Scheme

CSA - Coordination and support action

Coordinator

QIAGEN GMBH
Address
Qiagen Strasse 1
40724 Hilden
Germany
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 372 831,25

Participants (18)

LGC LIMITED
United Kingdom
EU contribution
€ 73 398,75
Address
Queens Road
TW11 0LY Teddington
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
TECHNISCHE UNIVERSITAET MUENCHEN
Germany
EU contribution
€ 100 875
Address
Arcisstrasse 21
80333 Muenchen
Activity type
Higher or Secondary Education Establishments
DIN DEUTSCHES INSTITUT FUER NORMUNG E.V.
Germany
EU contribution
€ 199 625
Address
Burggrafenstrasse 6
10787 Berlin
Activity type
Other
PREANALYTIX GMBH
Switzerland
EU contribution
€ 0
Address
Feldbachstrasse
8634 Hombrechtikon
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
INIVATA LIMITED
United Kingdom
EU contribution
€ 0
Address
Li Ka Shing Centre Robinson Way
CB2 0RE Cambridge
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
CAMBRIDGE PROTEIN ARRAYS LTD
United Kingdom
EU contribution
€ 97 000
Address
Babraham Hall, Babraham Research Campus
CB22 3AT Cambridge
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
TATAA BIOCENTER AB
Sweden
EU contribution
€ 75 875
Address
Odinsgatan 28
411 03 Goteborg
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
UNIVERSITA DEGLI STUDI DI FIRENZE
Italy
EU contribution
€ 102 875
Address
Piazza San Marco 4
50121 Florence
Activity type
Higher or Secondary Education Establishments
CONSORZIO INTERUNIVERSITARIO RISONANZE MAGNETICHE DI METALLO PROTEINE
Italy
EU contribution
€ 61 375
Address
Piazza San Marco 4
50121 Firenze
Activity type
Higher or Secondary Education Establishments
UNIVERSITA DEGLI STUDI DI TRIESTE
Italy
EU contribution
€ 84 750
Address
Piazzale Europa 1
34127 Trieste
Activity type
Higher or Secondary Education Establishments
UNIVERSITA DEGLI STUDI DI TORINO
Italy
EU contribution
€ 78 375
Address
Via Giuseppe Verdi 8
10124 Torino
Activity type
Higher or Secondary Education Establishments
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM (BBMRI-ERIC)
Austria
EU contribution
€ 100 673,75
Address
Neue Stiftingtalstrasse 2/B/6
8010 Graz
Activity type
Research Organisations
LUXEMBOURG INSTITUTE OF HEALTH
Luxembourg
EU contribution
€ 152 500
Address
Val Fleuri 84
1526 Luxembourg
Activity type
Research Organisations
MEDIZINISCHE UNIVERSITAT GRAZ
Austria
EU contribution
€ 158 318,75
Address
Auenbruggerplatz 2
8036 Graz
Activity type
Higher or Secondary Education Establishments
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France
EU contribution
€ 82 750
Address
Rue De Tolbiac 101
75654 Paris
Activity type
Research Organisations
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Netherlands
EU contribution
€ 118 750
Address
Dr Molewaterplein 40
3015 GD Rotterdam
Activity type
Higher or Secondary Education Establishments
FUNDACIO CENTRE DE REGULACIO GENOMICA
Spain
EU contribution
€ 88 750
Address
Carrer Doctor Aiguader 88
08003 Barcelona
Activity type
Research Organisations
FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI
Italy
EU contribution
€ 51 250
Address
Via Venezian 1
20133 Milan
Activity type
Research Organisations